Queen’s funds COVID studies by KGHRI and KHSC clinician scientists and researchers
Five clinician-scientists and researchers associated with the Kingston General Health Research Institute and Kingston Health Sciences Centre are among 13 recipients of Queen’s University’s Rapid Response funding competition supporting COVID-19 research.
“It is fantastic to see our researchers funded to address a diverse array of critical health-related issues associated with COVID-19 that has the potential to broadly impact patients, care providers and the community, particularly our most vulnerable populations,” says Steve Smith, Vice-Dean Research, Faculty of Heath Sciences, Queen’s, Vice President, Health Sciences Research, KHSC and President & CEO, KGHRI. “Congratulations to our investigators for the ingenuity and speed with which they’ve responded to this global health challenge.”
The successful projects include:
Stephen Archer (Medicine) – Synthesis and preclinical testing of novel small molecule therapies for COVID-19.
Nazanin Alavi (Psychiatry) – Online delivery of psychotherapy, tailored to patients' suffering from mental health problems due to COVID-19 pandemic.
Xiaolong Yang (Pathology and Molecular Medicine) – Developing a biosensor tool using an ultra-bright bioluminescent enzyme purified from glowing deep-sea shrimp to "visualize" and quantify the interaction between viruses and cells.
Amy Wu (Mechanical and Materials Engineering) – Designing, testing, and evaluating low-cost, medical grade face shields that can be easily produced by the rapid prototyping
Imaan Bayoumi (Family Medicine) – Exploring the hidden social, emotional and mental health impacts of the COVID-19 pandemic and public health countermeasures on residents of Kingston and area, with a focus on marginalized groups such as those using substances, living in poverty, single parents, children or people suffering from mental health conditions, chronic health conditions and family conflict.
The full Queen’s list can be viewed here.